Talk to Robyn

00 1 718 213 49 04

Search inside this page

All regions

Free Market Research Guides to Download

Prescription Drug Analysis & Statistics, May 2013

» Purchase Premium Reports

1-40 of about 100 reports
Prescription Drugs Markets in China

Prescription Drugs Markets in China

  • $ 2 000
  • Industry report
  • April 2013
  • by Asia Market Information & Development Company

China's demand for prescription drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, ...

  • Industries : Prescription Drug
  • Countries : China
Mexico Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • February 2013
  • by Business Monitor International

BMI View: Theoretically, Mexico offers one of the most favourable intellectual property (IP) environments in Latin America, which will continue to prop up multinational interest in the country's pharmaceutical ...

  • Industries : Prescription Drug
  • Countries : Mexico
Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

BMI View: Bulgaria's pharmaceutical industry will be under some pressure in 2012 due to a weakening economic outlook and the tightening of publicly funded healthcare services. However, we have broadly ...

  • Industries : Prescription Drug
  • Countries : Bulgaria
Portugal Business Projection Industry Update Quarter 2 2012

Portugal Business Projection Industry Update Quarter 2 2012

  • $ 1 050
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates Core Views Portugal is in the midst of a deep recession that will last until at least 2013. We do not see substantially higher growth beyond this. We are expecting contractions ...

  • Industries : Prescription Drug
  • Countries : Portugal
Chemipal Ltd. (Symbol:CMPL) SWOT Analysis, Strategy, Revenues and Profits

Chemipal Ltd. (Symbol:CMPL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Prescription Drug
  • Countries : Israel

United States Prescription Drug Sales, Us$bn, % Chg Y-o-y

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2003 To 2021
By Business Monitor International
Source: IMS Health, Pharmaceutical Research and Manufacturers of America (PhRMA), Food and Drug Administrati

  • Industries : Prescription Drug
  • Countries : United States

France Prescription Drug Sales, Us$bn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2021
By Business Monitor International
Source: French Directorate for Research, Studies, Evaluation and Statistics (DREES), IMS Health, Association

  • Industries : Prescription Drug
  • Countries : France

Australia Prescription Drug Sales, Us$bn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI

  • Industries : Prescription Drug
  • Countries : Australia

United Kingdom Prescription Drug Sales, Us$bn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: IMS Health, Organisation for Economic Cooperation and Development (OECD), BMI

  • Industries : Prescription Drug
  • Countries : United Kingdom

United States Prescription Drug Sales, Us$bn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2021
By Business Monitor International
Source: IMS Health, Pharmaceutical Research and Manufacturers of America (PhRMA), Food and Drug Administrati

  • Industries : Prescription Drug
  • Countries : United States

United Kingdom Prescription Drug Sales, Us$bn, % Chg Y-o-y

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2005 To 2021
By Business Monitor International
Source: IMS Health, Organisation for Economic Cooperation and Development (OECD), BMI

  • Industries : Prescription Drug
  • Countries : United Kingdom
Acasti Pharma Inc. (APO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acasti Pharma Inc. (APO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2013
  • by Global Data

Summary Acasti Pharma Inc. (Acasti) is a biopharmaceutical company. It undertakes the research, development and commercialization of novel proprietary active pharmaceutical ingredients (APIs) for the management ...

  • Industries : Prescription Drug
Axxess Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Axxess Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2013
  • by Global Data

Summary Axxess Pharma, Inc. is engaged in commercialization of dermatological, therapeutic nutritionals, pain management and diagnostic products. The company is headquartered in Ontario, Canada. Axxess ...

  • Industries : Prescription Drug
  • Countries : Canada

Brazil Prescription Drug Sales, Us$bn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: The Brazilian Pharmaceutical Industry Federation (Febrafarma), Group of Executives of the Pharmaceut

  • Industries : Prescription Drug
  • Countries : Brazil

Australia Prescription Drug Sales, Us$bn, % Chg Y-o-y

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2005 To 2021
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI

  • Industries : Prescription Drug
  • Countries : Australia

Canada Prescription Drug Sales, Us$bn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: Canadian Generic Pharmaceutical Association (CGPA), Patented Medicine Prices Review Board (PMPRB), B

  • Industries : Prescription Drug
  • Countries : Canada

South Korea Prescription Drug Sales, Us$bn

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2002 To 2021
By Business Monitor International
Source: Korea Pharmaceutical Manufacturers Association (KPMA), BMI

  • Industries : Prescription Drug
  • Countries : South Korea
Shoppers Drug Mart Inc in Retailing (Canada)

Shoppers Drug Mart Inc in Retailing (Canada)

  • $ 153
  • Company report
  • March 2013
  • by Euromonitor International

Shoppers continues on its course of building growth through acquisition, as well as building generic and private label prescription drug sales in key markets as drugstores grappled with new government ...

  • Industries : Prescription Drug
  • Countries : Canada
CR Sanjiu Medical & Pharmaceutical Co Ltd in Consumer Health (China)

CR Sanjiu Medical & Pharmaceutical Co Ltd in Consumer Health (China)

  • $ 153
  • Company report
  • April 2013
  • by Euromonitor International

CR Sanjiu Medical & Pharmaceutical Co Ltd aims to continue to establish itself as one of the leading pharmaceutical players in China over the forecast period. To realise this goal, CR Sanjiu has formed ...

  • Industries : Prescription Drug
  • Countries : China
Jean Coutu Group (PJC) Inc in Retailing (Canada)

Jean Coutu Group (PJC) Inc in Retailing (Canada)

  • $ 153
  • Company report
  • March 2013
  • by Euromonitor International

As the legislative changes to prescription drugs across Canada take effect, which aim to favour sales of generic prescription drugs in order to lower costs for Canadians, Jean Coutu witnessed sales of ...

  • Industries : Prescription Drug
  • Countries : Canada
Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review

Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • March 2013
  • by Global Data

Summary Abbott India Limited (Abbott India), a subsidiary of Abbott Laboratories, is an Indian pharmaceutical company that discovers, develops, manufactures and markets pharmaceutical, diagnostic, and ...

  • Industries : Prescription Drug
  • Countries : India
Green Cross Corporation (Symbol:006280) SWOT Analysis, Strategy, Revenues and Profits

Green Cross Corporation (Symbol:006280) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Prescription Drug
  • Countries : Thailand
Purdue Pharma L.P. SWOT Analysis, Strategy, Revenues and Profits

Purdue Pharma L.P. SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Prescription Drug
  • Countries : United States
HealthWarehouse.com, Inc - Company Capsule

HealthWarehouse.com, Inc - Company Capsule

  • $ 99
  • Company report
  • May 2013
  • by Canadean Ltd

Synopsis Canadean's "HealthWarehouse.com, Inc - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products ...

  • Industries : Prescription Drug
  • Countries : United States
Mexico Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • February 2013
  • by Business Monitor International

BMI View: Theoretically, Mexico offers one of the most favourable intellectual property (IP) environments in Latin America, which will continue to prop up multinational interest in the country's pharmaceutical ...

  • Industries : Prescription Drug
  • Countries : Mexico
Nigeria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Nigeria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • February 2013
  • by Business Monitor International

BMI View: As the most populous country on the African continent, Nigeria should be of interest to multinational drugmakers. However, extremely low per capita spending on medicines, rampant counterfeiting ...

  • Industries : Prescription Drug
  • Countries : Nigeria
United Arab Emirates Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

United Arab Emirates Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 088
  • Industry report
  • February 2013
  • by Business Monitor International

The Three Tiers Of The MEA Region The countries of the Middle East and Africa (MEA) region vary greatly in the regulation of their local pharmaceutical markets, macroeconomic environments, patent protection ...

  • Industries : Prescription Drug
  • Countries : United Arab Emirates
Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 088
  • Industry report
  • February 2013
  • by Business Monitor International

BMI calculates that pharmaceutical revenues in Venezuela, under pressure from economic and pricing factors, reached VEB12.76bn (US Dollar 5.95bn) in 2009, a 31.2% local currency year-on-year (y-o-y) increase. ...

  • Industries : Prescription Drug
  • Countries : Venezuela
Sri Lanka Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Sri Lanka Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 088
  • Industry report
  • February 2013
  • by Business Monitor International

BMI View: Sri Lanka's pharmaceutical industry is expected to post a from 2010 to 2015 compound annual growth rate (CAGR) of 10.2%, as measured in local currency terms. Nevertheless, by 2015, the industry ...

  • Industries : Prescription Drug
  • Countries : Sri Lanka
Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 088
  • Industry report
  • January 2013
  • by Business Monitor International

BMI View: It is beyond doubt that drugmakers in Greece - particularly domestic producers primarily exposed to their home industry - are faced with the most challenging operating environment in Europe. ...

  • Industries : Prescription Drug
  • Countries : Greece
United States Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

United States Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 088
  • Industry report
  • January 2013
  • by Business Monitor International

BMI View: Healthcare spending in the US will continue to account for a disproportionately large percentage of its Gross Domestic Product . Citizens of the world's largest economy are accustomed to regula ...

  • Industries : Prescription Drug
  • Countries : United States
Ghana Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Ghana Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 088
  • Industry report
  • January 2013
  • by Business Monitor International

BMI View: Ghana's pharmaceutical industry is expected to post double-digit year-on-year (y-o-y) growth again in 2011, which will partly be due to inflation. Per capita spending on medicines will remain ...

  • Industries : Prescription Drug
  • Countries : Ghana
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 088
  • Industry report
  • January 2013
  • by Business Monitor International

BMI View: The Belarusian pharmaceutical industry has strong long-term potential given its position bordering the EU and Russia, its demographic profile and still low per capita spending on pharmaceuticals. ...

  • Industries : Prescription Drug
  • Countries : Belarus
Bahrain Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Bahrain Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 088
  • Industry report
  • January 2013
  • by Business Monitor International

BMI View: The countries of the Gulf Cooperation Council (GCC) have plenty of opportunities for newly established drug manufacturers. The political will from governments seeking to diversify their economies ...

  • Industries : Prescription Drug
  • Countries : Bahrain
Walgreen Co. (Symbol:WAG) SWOT Analysis, Strategy, Revenues and Profits

Walgreen Co. (Symbol:WAG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2013
  • by Global Data

Walgreen Co. (Walgreens) is a company engaged in retail drugstore business. The company has store at 8046 locations in 50 states of the US, the District of Columbia, Guam and Puerto Rico. The drugstores ...

  • Industries : Prescription Drug
  • Countries : United States
Peru Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Peru Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 088
  • Industry report
  • January 2013
  • by Business Monitor International

BMI View: Despite its steady growth over the past decade, Peru remains a relatively small pharmaceutical industry - valued at no more than US Dollar 1.1bn in 2010 - despite the population size nudging ...

  • Industries : Prescription Drug
  • Countries : Peru
Puerto Rico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Puerto Rico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 088
  • Industry report
  • January 2013
  • by Business Monitor International

BMI View: Puerto Rico has long held a reputation as a hotspot for foreign pharmaceutical investment, due to its low cost base and affiliation as a US territory with commonwealth status, offering investors ...

  • Industries : Prescription Drug
  • Countries : United States, Dominican Republic, Dominica, Switzerland, Singapore, North America, Canada
Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 088
  • Industry report
  • December 2012
  • by Business Monitor International

BMI View: Out-of-pocket spending will continue to be the main driver behind the growth of Bulgaria's pharmaceutical industry, though this feature also makes the industry highly vulnerable to the wide ...

  • Industries : Prescription Drug
  • Countries : Bulgaria
Lloydspharmacy | Verdict Company Briefing, Verdict Research Ltd

Lloydspharmacy | Verdict Company Briefing, Verdict Research Ltd

  • $ 400
  • Company report
  • December 2012
  • by Verdict Research Ltd

Lloydspharmacy continues to face increasing competition as grocers expand their pharmacy portfolios. As a result the retailer needs to focus on its point of differentiation - its neighbourhood locations. ...

  • Industries : Prescription Drug
  • Countries : United Kingdom
Tien Liang BioTech Co., Ltd.: Company Capsule

Tien Liang BioTech Co., Ltd.: Company Capsule

  • $ 99
  • Company report
  • November 2012
  • by Canadean Ltd

Synopsis Canadean's "Tien Liang BioTech Co., Ltd. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, majo ...

  • Industries : Prescription Drug
  • Countries : Taiwan, China

» Read our Company Profiles

1 Companies

GlaxoSmithKline P.L.C.

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.